Mirvie Granted Breakthrough Device Designation For Test To Identify Risk Of Preeclampsia
Executive Summary
Mirvie’s RNA platform can identify 75% of women who develop preeclampsia months before symptoms occur.
You may also be interested in...
Minute Insight: Smith + Nephew Expands VR-based Surgical Training
Smith + Nephew is expanding its suite of simulation technologies to train surgeons on new techniques before they enter the operating room.
BTIG Analyst Zooms Into Alcon’s Revamp Into ‘Building A Pharma Company Inside A Device Company’
In his recent report on Alcon, BTIG analyst Ryan Zimmerman estimated that its pharmaceutical portfolio could generate close to $900m in fiscal year 2022.
AI-based Start-Up Aidoc Has Big Plans For Health Integration Beyond Reading Radiology Scans
Aidoc’s AI-based software is integrated in more than 1,000 medical centers. The company has raised a total of $250m in VC money, which will be used to expand its technology beyond radiology.